The generic pharmaceutical industry focuses on producing medications that are equivalent to brand-name drugs, allowing for cost-effective healthcare solutions. This sector thrives on companies that are dedicated to research, manufacturing, and distribution, often highlighting their commitment to quality and accessibility. As global healthcare demands grow, the industry is shifting toward advanced drug formulations and personalized medicine, prompting innovation. With regulatory landscapes evolving, companies are now more invested in compliance and sustainability. Emerging markets present new opportunities, making this an exciting time for generic pharmaceutical players to expand their reach and enhance their product offerings.

This list showcases 23 notable companies operating within the generic pharmaceuticals sector. They range from large enterprises with over 10,000 employees to smaller firms with just a few hundred staff. Headquartered across multiple countries including Canada, India, Brazil, and Egypt, these companies were founded between the mid-20th century and the early 2000s. While specializing in the production of generic drugs, they also offer branded generics in various therapeutic areas. This collection represents a significant cross-section of the industry's growth and its future direction in improving health outcomes globally.

Continue reading to discover the top generic pharmaceutical companies.

Top 23 Generic Pharmaceuticals Companies

1. Apotex Inc.

• Website: apotex.com
• Ownership type: Private Equity
• Headquarters: Toronto, Ontario, Canada
• Employee distribution: Canada 68%, India 17%, Mexico 8%, Other 7%
• Latest funding: September 2022
• Founded year: 1974
• Headcount: 10001+
• LinkedIn: apotex-inc-

Apotex Inc. is a Canadian-based pharmaceutical company headquartered in Toronto, Ontario. Established in 1974, Apotex specializes in the production and distribution of generic medications, catering to healthcare providers, pharmacies, and patients. The company offers a wide range of over 300 products, providing affordable alternatives to brand-name drugs for various health conditions. Apotex operates on a global scale, with a presence in more than 115 countries, and employs a workforce of over 6,000 individuals, primarily in Canada, India, and Mexico. The company is dedicated to maintaining high standards of quality and accessibility in healthcare, which is evident in its extensive research and development efforts aimed at ensuring the safety and efficacy of its products. Apotex's commitment to corporate responsibility and sustainable practices further enhances its standing in the pharmaceutical industry.

2. Ems

• Website: ems.com.br
• Ownership type: Private
• Headquarters: Hortolândia, Sao Paulo, Brazil
• Employee distribution: Brazil 99%, Other 1%
• Latest funding: Other (Debt), $91.1M, August 2024
• Founded year: 1964
• Headcount: 1001-5000
• LinkedIn: ems

Ems, founded in 1964 and based in Hortolândia, São Paulo, Brazil, is a private pharmaceutical manufacturer that specializes in generic medications. With a workforce of over 12,000 employees, the company has carved out a significant position in the Brazilian pharmaceutical industry, particularly in terms of sales and units sold. Ems is dedicated to making healthcare more accessible by offering a range of affordable medication options. The company has also engaged in various initiatives to support healthcare education and awareness, reflecting its commitment to public health. Recently, Ems secured funding of approximately $91 million, which underscores its active role in the market and potential for growth.

3. Intas Pharmaceuticals

• Website: intaspharma.com
• Ownership type: Private Equity
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 99%, Other 1%
• Latest funding: October 2022
• Founded year: 2000
• Headcount: 10001+
• LinkedIn: intas-biopharmaceuticals

Intas Pharmaceuticals Limited, based in Ahmedabad, Gujarat, India, is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic therapeutic drugs. Founded in 2000, Intas has grown significantly, employing over 17,000 people and serving healthcare professionals in more than 85 countries. The company is dedicated to addressing unmet medical needs through innovative products and a strong commitment to quality. Intas operates a vertically integrated business model, which allows it to control the entire pharmaceutical value chain, from research and development to manufacturing and marketing. The company has a robust product portfolio that includes generics, oncology products, and added-value products. Intas is also recognized for its investment in research and development, with a dedicated team of over 550 scientists and advanced facilities that support its innovative efforts. The company has received various global regulatory approvals, ensuring that its products meet the highest quality standards. Intas continues to expand its reach in international markets, particularly in the highly regulated markets of the EU and the US, where it generates a significant portion of its revenue.

4. Pharco Corporation

• Website: pharco.org
• Ownership type: Private
• Headquarters: Alexandria, Scotland, United Kingdom (UK)
• Employee distribution: Egypt 95%, Saudi Arabia 3%, Other 2%
• Latest funding: IPO, May 2006
• Founded year: 1987
• Headcount: 5001-10000
• LinkedIn: pharco-corporation

Pharco Corporation, based in Alexandria, Egypt, is a prominent pharmaceutical manufacturer that specializes in the development, production, and marketing of a wide array of pharmaceutical products. Founded in 1987, Pharco has grown to become the largest manufacturer of pharmaceuticals in Egypt and a key player in the MENA region. The company focuses on generics and branded generics, with a particular emphasis on providing affordable treatments for diseases such as Hepatitis C. Pharco operates through multiple subsidiaries, producing over 450 brands and exporting to more than 50 countries. The company is dedicated to research and development, ensuring that they remain at the forefront of pharmaceutical innovation. With a workforce of over 8,000 employees, Pharco is committed to delivering safe and effective medications to healthcare providers and patients alike.

5. Medochemie Ltd

• Website: medochemie.com
• Ownership type: Private
• Headquarters: Limassol, Limassol, Cyprus
• Employee distribution: Cyprus 46%, Greece 13%, Romania 6%, Other 35%
• Founded year: 1976
• Headcount: 1001-5000
• LinkedIn: medochemie-ltd

Medochemie Ltd, based in Limassol, Cyprus, is a pharmaceutical company that specializes in the development, manufacturing, and distribution of branded generic and patented medications. Established in 1976 by Dr. Andreas Pittas, the company has grown to operate 15 manufacturing sites, including facilities in Cyprus, the Netherlands, and Vietnam. Medochemie holds over 5,145 marketing authorizations for approximately 630 pharmaceutical products across more than 10 therapeutic categories. The company is dedicated to providing quality drug treatments at affordable prices, serving healthcare providers and organizations in 122 countries. With a workforce of around 2,000 employees, Medochemie emphasizes quality assurance and adheres to Good Manufacturing Practices (cGMPs) as mandated by the European Union and the World Health Organization. Their operations also include contract manufacturing and licensing, further solidifying their role in the pharmaceutical industry.

6. Ultra Laboratorios

• Website: ultralaboratorios.com.mx
• Ownership type: Private
• Headquarters: Guadalajara, Jalisco, Mexico
• Employee distribution: Mexico 100%
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: ultra-laboratorios-s-a--de-c-v-

Ultra Laboratorios S.A. de C.V. is a Mexican pharmaceutical company founded in 2001, headquartered in Guadalajara, Jalisco. The company specializes in the development, manufacturing, and distribution of generic medicines, catering to healthcare professionals, pharmacies, and consumers. Ultra Laboratorios is known for its commitment to producing high-quality, safe, and effective pharmaceutical products across various therapeutic classes, including antibiotics, antivirals, antifungals, and medications for cardiovascular and gastrointestinal health. With a robust research and development department, the company emphasizes innovation and continuous improvement in its processes. Ultra Laboratorios operates a modern manufacturing facility designed with advanced technology, allowing for a significant production capacity of oral solid medicines. The company is dedicated to ensuring the well-being of its customers and maintaining high standards of pharmaceutical ethics. Their products are distributed throughout Mexico, and they have established partnerships with various pharmacy chains and distributors, further solidifying their presence in the market.

7. Alvogen

• Website: alvogen.com
• Ownership type: Corporate
• Headquarters: Montville, New Jersey, United States (USA)
• Latest funding: Other (Debt), $669.0M, March 2025
• Founded year: 2009
• Headcount: 1001-5000
• LinkedIn: alvogen

Alvogen is a privately owned pharmaceutical company based in Montville, New Jersey, founded in 2009. The company specializes in the development, manufacturing, and marketing of generic medications, injectables, and over-the-counter products. Alvogen aims to serve healthcare providers, pharmacies, and patients by providing high-quality medicines that are both accessible and affordable. With a targeted portfolio that includes complex inhalation products and strategic 505(b)(2) products, Alvogen has over 50 products currently on the market. The company operates a manufacturing facility in Norwich, New York, which has a long-standing regulatory track record. Alvogen's commitment to quality and innovation is evident in its extensive R&D capabilities, which fuel its growing pipeline. The company has also received significant funding, amounting to $669 million, which supports its ongoing efforts to expand its product offerings and market presence.

8. ratiopharm

• Website: ratiopharm.de
• Ownership type: Corporate
• Headquarters: Ulm, Baden-Württemberg, Germany
• Employee distribution: Germany 58%, Austria 22%, Spain 13%, Other 6%
• Latest funding: $4.0B, March 2010
• Founded year: 1973
• Headcount: 1001-5000
• LinkedIn: ratiopharm

ratiopharm GmbH, based in Ulm, Baden-Württemberg, Germany, is a pharmaceutical company that has been operational since 1973. The firm specializes in the production and distribution of generic and over-the-counter medications, catering to pharmacies and consumers alike. With a workforce of approximately 581 employees, ratiopharm is a mid-sized entity in the pharmaceutical landscape. The company offers a wide array of products, totaling around 2,500, which address various health needs, from pain relief to vitamin supplementation. As part of the Teva Group, ratiopharm benefits from advanced research and technology, allowing it to maintain a competitive edge in the generic market. Their commitment to quality and affordability is encapsulated in their slogan, "Gute Preise. Gute Besserung." This reflects their mission to ensure access to essential medications at fair prices. Additionally, ratiopharm is engaged in sustainable practices and social initiatives, further solidifying its role in the healthcare sector.

9. betapharm Arzneimittel GmbH

• Website: betapharm.de
• Ownership type: Corporate
• Headquarters: Augsburg, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: $577.4M, March 2006
• Founded year: 1993
• Headcount: 10001+
• LinkedIn: betapharm-arzneimittel-gmbh

betapharm Arzneimittel GmbH, established in 1993 and based in Augsburg, Bavaria, Germany, is a pharmaceutical company that specializes in the production and distribution of generic medications. The company serves pharmacies and healthcare professionals, providing a wide range of affordable and quality pharmaceutical products. With a portfolio that includes over 150 active ingredients in more than 900 dosage forms, betapharm addresses various medical needs, including cardiovascular, neurological, and pain management therapies. Since becoming part of the international Dr. Reddy’s Laboratories group in 2006, betapharm has strengthened its position in the market, focusing on enhancing patient care through accessible medication options. Their commitment to corporate social responsibility and transparency further underscores their role in the healthcare industry.

10. Joswe Medical

• Website: joswe.com
• Ownership type: Private
• Headquarters: Amman, Amman Governorate, Jordan
• Employee distribution: Jordan 76%, Iraq 10%, Saudi Arabia 8%, Other 6%
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: joswe-medical

Joswe Medical, established in 1996, is a prominent pharmaceutical manufacturer located in Amman, Jordan. The company specializes in the development and production of high-quality branded first generic medicines. With a workforce of approximately 439 employees, Joswe Medical serves healthcare providers, pharmacies, and patients across the MENA region. The company has a strong focus on increasing the availability and affordability of critical medications, which is evident in their extensive product portfolio that includes over 160 pharmaceutical products across 14 therapeutic categories. Joswe is recognized as the first pharmaceutical company in Jordan to manufacture quality branded first generic CNS medicines. Their commitment to quality and compliance is reflected in their adherence to various regulatory standards, ensuring that their products meet safety and efficacy requirements. Joswe Medical continues to expand its market presence and product offerings, aiming to address critical healthcare needs in the region.

11. Sandoz Canada

• Website: sandoz.ca
• Ownership type: Corporate
• Headquarters: Boucherville, Quebec, Canada
• Employee distribution: Canada 100%
• Latest funding: May 2018
• Founded year: 1980
• Headcount: 201-500
• LinkedIn: sandozcanada

Sandoz Canada, established in 1980 and located in Boucherville, Quebec, is a corporate entity that specializes in the development and distribution of generic and biosimilar medicines. With a workforce of approximately 234 employees, Sandoz Canada plays a significant role in the pharmaceutical landscape by ensuring that healthcare professionals and patients have access to affordable medications. The company emphasizes innovation and quality in its product offerings, which include a wide range of generics and biosimilars. Sandoz Canada is dedicated to meeting the needs of the healthcare industry, and their commitment to corporate responsibility further underscores their relevance in the pharmaceutical sector. They also provide patient support programs, enhancing their engagement with the community and healthcare providers.

12. Medical Union Pharmaceuticals

• Website: mupeg.com
• Ownership type: Private
• Headquarters: Cairo, Cairo Governorate, Egypt
• Employee distribution: Egypt 97%, Other 3%
• Founded year: 1984
• Headcount: 1001-5000
• LinkedIn: medical-union-pharmaceuticals-mup

Medical Union Pharmaceuticals (MUP), based in Cairo, Egypt, is a private pharmaceutical manufacturer that has been operational since 1984. The company is dedicated to the development, manufacturing, and marketing of a wide array of branded and generic medications. MUP serves healthcare providers and patients primarily in the Middle East, Africa, and Asia, with a strong emphasis on delivering high-quality and affordable medicines. The company boasts a portfolio of over 200 products, including both branded generics and biosimilars, and has a robust pipeline of products under development. MUP operates four manufacturing facilities, producing more than 200 million units annually, and has established a significant export presence, reaching over 40 countries. Their commitment to quality is underscored by their compliance with international standards and regulations, ensuring that their products meet the necessary safety and efficacy requirements. MUP also invests in research and development to innovate and improve healthcare solutions for patients.

13. Opsonin Pharma Ltd

• Website: opsonin-pharma.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 99%
• Founded year: 1956
• Headcount: 5001-10000
• LinkedIn: opsonin-pharma

Opsonin Pharma Ltd, based in Dhaka, Bangladesh, is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic medicines for human use. Founded in 1956, Opsonin has grown to become a significant player in the pharmaceutical industry, producing over 350 brands and more than 800 stock-keeping units (SKUs). The company is dedicated to improving healthcare quality both locally and internationally, ensuring access to affordable medications for healthcare providers and consumers alike. Opsonin Pharma also manufactures agrovet products, further diversifying its portfolio. The company has made substantial investments in modern manufacturing facilities that comply with international regulatory standards, including those set by the US-FDA and EU. Opsonin's commitment to quality and innovation is evident in its continuous efforts to expand its product offerings and enhance its global presence, exporting to various regions including Asia, Africa, and the Middle East.

14. Par Pharmaceutical

• Website: parpharm.com
• Ownership type: Corporate
• Headquarters: Chestnut Ridge, New York, United States (USA)
• Employee distribution: India 57%, United States (USA) 42%
• Latest funding: $8.1B, May 2015
• Founded year: 1978
• Headcount: 501-1000
• LinkedIn: par-pharmaceutical

Par Pharmaceutical, a subsidiary of Endo International, is based in Chestnut Ridge, New York. Founded in 1978, the company specializes in the development and delivery of generic pharmaceuticals. Par Pharmaceutical is dedicated to providing high-quality generic medications across various forms and dosages, including oral solids, injectables, and other delivery systems. Their focus on research and development allows them to address unmet patient needs effectively. With a workforce of approximately 1,415 employees, the company operates with a strong commitment to compliance and customer service, ensuring that their products meet rigorous industry standards. Par Pharmaceutical has a significant presence in the U.S. market, where it dispenses millions of prescriptions each month, reflecting its active role in improving healthcare outcomes.

15. Zydus Pharmaceuticals (USA) Inc.

• Website: zydususa.com
• Ownership type: Private
• Headquarters: Pennington, New Jersey, United States (USA)
• Employee distribution: United States (USA) 56%, India 40%, Other 4%
• Founded year: 2005
• Headcount: 51-200
• LinkedIn: zydus-pharmaceuticals-usa-inc-

Zydus Pharmaceuticals (USA) Inc., based in Pennington, New Jersey, is a pharmaceutical company that focuses on the manufacturing and distribution of generic and branded medications. Founded in 2005, Zydus has grown to offer over 500 stock-keeping units (SKUs) in the U.S. market. The company is recognized for its commitment to providing high-quality, FDA-approved products that aim to enhance patient health and wellness. Zydus operates under the umbrella of Zydus Lifesciences, a global healthcare provider with a presence in over 50 countries. The company has made significant strides in the generic market, filing over 129 drug master files and receiving final USFDA approval on 287 Abbreviated New Drug Applications (ANDAs). With more than 85 ANDAs pending approval and around 300 additional products in various stages of development, Zydus Pharmaceuticals is well-positioned to continue its impact in the pharmaceutical industry.

16. Synthon

• Website: synthon.com
• Ownership type: Private Equity
• Headquarters: Nijmegen, Gelderland, Netherlands
• Employee distribution: Spain 38%, Netherlands 23%, Chile 15%, Other 25%
• Latest funding: December 2024
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn: synthon

Synthon, founded in 1991 and based in Nijmegen, Netherlands, is a pharmaceutical company that specializes in the development, manufacturing, and commercialization of complex generic medicines. With a workforce of approximately 1,320 employees, the company operates globally, with significant operations in Spain, Chile, Argentina, the Czech Republic, and Mexico. Synthon's portfolio includes a wide range of high-quality generic products across various therapeutic areas, including oncology and central nervous system disorders. The company prides itself on its innovative approach to drug development, utilizing advanced technologies and rigorous scientific methodologies to ensure the safety and efficacy of its products. Synthon also maintains a vertically integrated manufacturing network, which enhances its reliability and quality assurance. The company is committed to improving patient access to affordable medications and actively seeks partnerships to expand its reach in the market.

17. Saiph

• Website: saiph-labo.com
• Ownership type: Private
• Headquarters: Mohammedia, Ben Arous Governorate, Tunisia
• Employee distribution: Tunisia 96%, Iraq 2%, Other 2%
• Founded year: 1992
• Headcount: 501-1000
• LinkedIn: saiph

Laboratoires SAIPH, founded in 1992 and based in Mohammedia, Tunisia, is a pharmaceutical manufacturer specializing in generic medications. The company produces a range of products, including cardiovascular drugs and antibiotics, catering to healthcare providers, hospitals, and pharmacies. With a workforce of approximately 492 employees, Saiph operates five production facilities that manufacture various forms of medications, including sterile forms, cephalosporins, and soft gelatin capsules. The company is recognized as the first manufacturer of cardiovascular and antibiotic generics in Tunisia, reflecting its significant role in the local pharmaceutical market. Saiph is committed to quality and innovation, aiming to enhance access to essential medications while expanding its reach within the African market. The company has also engaged in partnerships with educational institutions to improve training in the pharmaceutical industry, further solidifying its position in the sector.

18. Healthcare Pharmaceuticals Limited

• Website: hplbd.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 98%, Other 2%
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: healthcare-pharmaceuticals-ltd

Healthcare Pharmaceuticals Limited (HPL), based in Dhaka, Bangladesh, is a private pharmaceutical manufacturer established in 1996. The company specializes in producing branded generic medicines, offering a wide range of products that cover various therapeutic classes, including antibiotics, anti-diabetics, and oncology medications. HPL is committed to ensuring high-quality medications for effective patient treatment, which is evident in their robust quality management systems and adherence to Good Manufacturing Practices (GMP). The company operates multiple specialized units, including solid, sterile, oncology, and hormone units, and emphasizes research and development to innovate and improve its product offerings. HPL has also made strides in international markets, actively seeking partnerships and registrations in various countries, which enhances its global footprint. With over 570 branded products across 250 generics, HPL is well-positioned in the pharmaceutical industry, catering to both local and overseas markets.

19. Hetero Healthcare Limited

• Website: heterohealthcare.com
• Ownership type: Private
• Headquarters: Hyderabad, Telangana, India
• Employee distribution: India 100%
• Founded year: 1994
• Headcount: 1001-5000
• LinkedIn: hetero-healthcare-limited

Hetero Healthcare Limited, based in Hyderabad, Telangana, India, is a private pharmaceutical company founded in 1994. With a workforce of approximately 1,690 employees, the company specializes in the development and manufacturing of generic drugs, particularly in the fields of oncology and antiretroviral (ARV) treatments. Hetero Healthcare is dedicated to enhancing the quality of life for patients through innovative pharmaceutical solutions. The company has made significant strides in research and development, evidenced by its successful launch of various generic medications, including the first generic version of Remdesivir in India. This initiative not only showcased their manufacturing capabilities but also their commitment to addressing critical healthcare challenges. Hetero Healthcare's infrastructure supports a robust R&D process, allowing them to respond effectively to market needs and patient demands. Their focus on continuous improvement and innovation positions them as a noteworthy entity in the pharmaceutical sector.

20. Nabiqasim Group

• Website: nabiqasim.com
• Ownership type: Private
• Headquarters: Karachi, Sindh, Pakistan
• Employee distribution: Pakistan 98%, Other 2%
• Founded year: 1967
• Headcount: 1001-5000
• LinkedIn: nabiqasim-group

Nabiqasim Industries (Pvt.) Ltd., founded in 1967 and based in Karachi, Pakistan, is a pharmaceutical manufacturer that specializes in branded generic formulations. The company is dedicated to providing high-quality, safe, and effective healthcare solutions across various medical fields, including cardiology, surgery, and psychiatry. With a workforce of approximately 1,429 employees, Nabiqasim operates a cGMP-compliant manufacturing facility that spans 120,000 square feet, equipped with modern machinery and infrastructure. Their commitment to quality is reinforced by independent quality control and assurance departments, ensuring that all products meet international standards. Nabiqasim has a strong market presence, exporting its products to over 50 countries, including regions in the Middle East, Central Asia, and Africa. The company also engages in contract manufacturing, further expanding its operational capabilities. Their flagship product, Acefyl, has been a top brand in the cough syrup category in Pakistan for 25 years, reflecting their success in the market. Nabiqasim's focus on innovation and quality positions it as a significant player in the pharmaceutical industry.

21. Globalpharma LLC

• Website: globalpharma.ae
• Ownership type: Corporate
• Headquarters: Dubai, Dubai, United Arab Emirates (UAE)
• Employee distribution: United Arab Emirates 78%, Saudi Arabia 17%, Other 4%
• Latest funding: $30.0M, September 2021
• Founded year: 1998
• Headcount: 201-500
• LinkedIn: global-pharma-llc

Globalpharma LLC, founded in 1998 and based in Dubai, UAE, is a pharmaceutical manufacturer focused on generic medicines. The company operates two manufacturing plants that adhere to current Good Manufacturing Practices (cGMP) and are approved by health authorities across the Middle East and parts of Africa. Globalpharma produces a wide range of products, including vitamins, anti-infectives, and medications for lifestyle diseases such as cardiovascular issues and diabetes. Their flagship products, like Gloclav® and Glomox®, are well-regarded in the market. The company has expanded its reach to 14 countries in the GCC and select African markets, demonstrating its growth trajectory. In 2021, Globalpharma secured $30 million in funding, which underscores its potential for further development and innovation in the pharmaceutical sector.

22. Laboratoires Galpharma

• Website: galpharma.tn
• Ownership type: Private
• Headquarters: Sfax, Sfax Governorate, Tunisia
• Employee distribution: Tunisia 100%
• Founded year: 1995
• Headcount: 201-500
• LinkedIn: galpharma

Laboratoires Galpharma is a pharmaceutical manufacturer located in Sfax, Tunisia, founded in 1995. The company specializes in the production of generic medications for human use, addressing various health conditions with a commitment to quality and safety. With a workforce of approximately 221 employees, Galpharma has established itself as a key player in the Tunisian pharmaceutical market. The company emphasizes the importance of using certified raw materials and adheres to European pharmacopoeia standards in its manufacturing processes. Galpharma's product range includes medications across multiple therapeutic classes, catering to both acute and chronic health issues. The company has invested in modern European equipment for its production facilities, which allows for the manufacture of solid, liquid, and semi-solid forms of medications. Galpharma's focus on quality and its strategic positioning in the local market contribute to its reputation as a reliable supplier of generic pharmaceuticals.

23. Neopharma

• Website: neopharma.com
• Ownership type: Private
• Headquarters: Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE)
• Employee distribution: United Arab Emirates 87%, Saudi Arabia 4%, Other 9%
• Founded year: 2003
• Headcount: 5001-10000
• LinkedIn: neopharmaglobal

Neopharma, established in 2003 and headquartered in Abu Dhabi, UAE, is a pharmaceutical manufacturer that specializes in producing high-quality medications, including both branded and generic formulations, as well as active pharmaceutical ingredients (APIs). The company operates a global manufacturing network with ten facilities across three continents, serving over 50 international markets. Neopharma's product portfolio includes more than 100 molecules across various therapeutic areas such as anti-infectives, cardiology, and oncology. The company is dedicated to innovation, focusing on research and development to create effective and affordable healthcare solutions. Neopharma has formed strategic partnerships and joint ventures with notable pharmaceutical companies, enhancing its capabilities in the market. Their commitment to quality is reflected in their adherence to stringent manufacturing standards and regulatory compliance, ensuring that their products meet the highest safety and efficacy benchmarks.

Generic Pharmaceuticals Insights: Key Companies

Company	Headquarter	Size	Founded	Ownership
Apotex Inc.	Toronto, Ontario, Canada	10001+	1974	Private Equity
Ems	Hortolândia, Sao Paulo, Brazil	1001-5000	1964	Private
Intas Pharmaceuticals	Ahmedabad, Gujarat, India	10001+	2000	Private Equity
Pharco Corporation	Alexandria, Scotland, United Kingdom (UK)	5001-10000	1987	Private
Medochemie Ltd	Limassol, Limassol, Cyprus	1001-5000	1976	Private
Ultra Laboratorios	Guadalajara, Jalisco, Mexico	1001-5000	2001	Private
Alvogen	Montville, New Jersey, United States (USA)	1001-5000	2009	Corporate
ratiopharm	Ulm, Baden-Württemberg, Germany	1001-5000	1973	Corporate
betapharm Arzneimittel GmbH	Augsburg, Bavaria, Germany	10001+	1993	Corporate
Joswe Medical	Amman, Amman Governorate, Jordan	1001-5000	1996	Private
Sandoz Canada	Boucherville, Quebec, Canada	201-500	1980	Corporate
Medical Union Pharmaceuticals	Cairo, Cairo Governorate, Egypt	1001-5000	1984	Private
Opsonin Pharma Ltd	Dhaka, Dhaka, Bangladesh	5001-10000	1956	Private
Par Pharmaceutical	Chestnut Ridge, New York, United States (USA)	501-1000	1978	Corporate
Zydus Pharmaceuticals (USA) Inc.	Pennington, New Jersey, United States (USA)	51-200	2005	Private
Synthon	Nijmegen, Gelderland, Netherlands	1001-5000	1991	Private Equity
Saiph	Mohammedia, Ben Arous Governorate, Tunisia	501-1000	1992	Private
Healthcare Pharmaceuticals Limited	Dhaka, Dhaka, Bangladesh	1001-5000	1996	Private
Hetero Healthcare Limited	Hyderabad, Telangana, India	1001-5000	1994	Private
Nabiqasim Group	Karachi, Sindh, Pakistan	1001-5000	1967	Private
Globalpharma LLC	Dubai, Dubai, United Arab Emirates (UAE)	201-500	1998	Corporate
Laboratoires Galpharma	Sfax, Sfax Governorate, Tunisia	201-500	1995	Private
Neopharma	Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE)	5001-10000	2003	Private

Want to Find More Generic Pharmaceuticals Companies?

If you want to find more companies that offer a wide range of generic medications and services you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!